What is Harvard MedTech?
Harvard MedTech is at the forefront of transforming trauma recovery with its proprietary virtual reality platform, Vx Therapy. This advanced solution is meticulously designed to address a spectrum of psychological and physical ailments, including pain, anxiety, depression, sleep disruption, and PTSD-related symptoms. Leveraging a decade of dedicated research, Vx Therapy has demonstrated remarkable efficacy, achieving a 96% satisfaction rate among both physicians and patients, with over 4,500 individuals benefiting from its holistic healing approach. The company's commitment to continuous improvement is evident through its strategic partnerships with leading organizations, all aimed at enhancing the Vx Therapy platform and profoundly impacting the lives of those affected by trauma.
How much funding has Harvard MedTech raised?
Harvard MedTech has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Harvard MedTech?
The substantial backing Harvard MedTech has received, particularly in this large-scale late-stage funding round, signals strong investor confidence in its market position and future growth potential. This strategic investment is expected to accelerate the company's expansion efforts, potentially enabling further development of the Vx Therapy platform, broader market penetration, and enhanced operational capabilities. The focus on trauma recovery through VR technology positions Harvard MedTech to capitalize on the growing demand for innovative mental and physical health solutions, suggesting a trajectory towards significant scaling and market leadership.
See full Harvard MedTech company page
